CN107951966B - 一种中藏药结合的浴足液 - Google Patents
一种中藏药结合的浴足液 Download PDFInfo
- Publication number
- CN107951966B CN107951966B CN201711166127.0A CN201711166127A CN107951966B CN 107951966 B CN107951966 B CN 107951966B CN 201711166127 A CN201711166127 A CN 201711166127A CN 107951966 B CN107951966 B CN 107951966B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- foot bath
- component
- bath liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 76
- 239000007788 liquid Substances 0.000 title claims abstract description 67
- 208000002193 Pain Diseases 0.000 claims abstract description 24
- 208000003251 Pruritus Diseases 0.000 claims abstract description 19
- 230000008961 swelling Effects 0.000 claims abstract description 19
- 241000229143 Hippophae Species 0.000 claims abstract description 17
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 210000003205 muscle Anatomy 0.000 claims abstract description 15
- 208000006820 Arthralgia Diseases 0.000 claims abstract description 13
- 206010016256 fatigue Diseases 0.000 claims abstract description 13
- 208000019116 sleep disease Diseases 0.000 claims abstract description 10
- 208000020685 sleep-wake disease Diseases 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 8
- 208000000112 Myalgia Diseases 0.000 claims abstract description 7
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 5
- 239000009636 Huang Qi Substances 0.000 claims abstract description 4
- 208000013465 muscle pain Diseases 0.000 claims abstract description 3
- 210000002683 foot Anatomy 0.000 claims description 125
- 244000020518 Carthamus tinctorius Species 0.000 claims description 30
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 30
- 244000205574 Acorus calamus Species 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000006480 Acorus calamus Nutrition 0.000 claims description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims description 15
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 15
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 15
- 241000132012 Atractylodes Species 0.000 claims description 14
- 241001289529 Fallopia multiflora Species 0.000 claims description 14
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 14
- 240000005373 Panax quinquefolius Species 0.000 claims description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 14
- 241000405414 Rehmannia Species 0.000 claims description 14
- 235000006533 astragalus Nutrition 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 14
- 244000042430 Rhodiola rosea Species 0.000 claims description 13
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 13
- 240000006079 Schisandra chinensis Species 0.000 claims description 13
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 12
- 241000045403 Astragalus propinquus Species 0.000 claims description 11
- 241000241550 Cyathula Species 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 241000382455 Angelica sinensis Species 0.000 claims description 7
- 244000146462 Centella asiatica Species 0.000 claims description 7
- 235000004032 Centella asiatica Nutrition 0.000 claims description 7
- 208000002173 dizziness Diseases 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 210000003127 knee Anatomy 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 244000179886 Moringa oleifera Species 0.000 claims 3
- 244000004281 Eucalyptus maculata Species 0.000 claims 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims 2
- 238000004821 distillation Methods 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 25
- 208000024891 symptom Diseases 0.000 abstract description 23
- 206010042674 Swelling Diseases 0.000 abstract description 18
- 239000000463 material Substances 0.000 abstract description 17
- 241000220215 Moringa Species 0.000 abstract description 14
- 239000000284 extract Substances 0.000 abstract description 11
- 206010013954 Dysphoria Diseases 0.000 abstract description 9
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 230000036961 partial effect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 244000166124 Eucalyptus globulus Species 0.000 description 26
- 230000017531 blood circulation Effects 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 239000000126 substance Substances 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 239000003651 drinking water Substances 0.000 description 16
- 235000020188 drinking water Nutrition 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000007803 itching Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 235000011996 Calamus deerratus Nutrition 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 8
- 238000003287 bathing Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000002147 killing effect Effects 0.000 description 8
- 244000061520 Angelica archangelica Species 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 description 7
- 241000246044 Sophora flavescens Species 0.000 description 7
- 244000045947 parasite Species 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000002040 relaxant effect Effects 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 241000167550 Centella Species 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 244000124209 Crocus sativus Species 0.000 description 6
- 235000015655 Crocus sativus Nutrition 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 6
- 238000001467 acupuncture Methods 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 241000913745 Spatholobus Species 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 235000013974 saffron Nutrition 0.000 description 5
- 239000004248 saffron Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- RKFAZBXYICVSKP-UHFFFAOYSA-N beta- asarone Natural products COC1=CC(OC)=C(C=CC)C=C1OC RKFAZBXYICVSKP-UHFFFAOYSA-N 0.000 description 4
- RKFAZBXYICVSKP-WAYWQWQTSA-N beta-asarone Chemical compound COC1=CC(OC)=C(\C=C/C)C=C1OC RKFAZBXYICVSKP-WAYWQWQTSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 241001061264 Astragalus Species 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 206010000059 abdominal discomfort Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 2
- 241001448624 Miliaria Species 0.000 description 2
- 206010027940 Mood altered Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 241001165494 Rhodiola Species 0.000 description 2
- 241000124033 Salix Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 208000018997 giddiness Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 230000007510 mood change Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000003997 social interaction Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000544682 Acorus tatarinowii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000131458 Elsholtzia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- YIJNZIXWHVONBS-ZZXKWVIFSA-N Precarthamin Chemical compound OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C(C(O)\C=C\C=2C=CC(O)=CC=2)=C1O YIJNZIXWHVONBS-ZZXKWVIFSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 240000000278 Syzygium polyanthum Species 0.000 description 1
- 235000008089 Syzygium polyanthum Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000022119 inability to concentrate Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 208000016334 muscle symptom Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- UVYRSIWRPCSELS-UHFFFAOYSA-N precarthamin Natural products OCC1OC(C(O)C(O)C1O)C2(O)C(=C(C(C(=O)O)C3=C(O)C(O)(C4OC(CO)C(O)C(O)C4O)C(=C(C(=O)C=Cc5ccc(O)cc5)C3=O)O)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O UVYRSIWRPCSELS-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种中藏药结合配方的精华养生浴足液,该浴足液是由以下原料组成:藏菖蒲、桉叶、苦参、红花、鸡血藤、川牛膝、白术、沙棘、当归、何首乌、红景天、雪莲花、黄芪、西洋参、五味子、熟地黄、积雪草、辣木籽。本发明提供的浴足液采用市场上渠道来源广泛的药材,通过不同比例的配比,提取出了一种能够养生浴足液,患者通过浴足的方式,解决部分人群的亚健康问题,即,本发明的产品能够缓解或消除亚健康人群因各种原因出现的疲乏无力、肌肉及关节酸痛、心烦意乱、焦躁不安、睡眠紊乱以及足部微生态失衡引起的肿痛瘙痒等亚健康症状。
Description
技术领域
本发明涉及一种具有浴足保健养生功能的中药、藏药结合的药物组合物。属于生命科学领域中调节人体功能的外用配方制剂技术。
背景技术
现代社会随着人们的工作、生活节奏的加快,不同人群各自的工作、生活、学习的压力不断增大,身体健康面临着严峻的挑战,容易出现似病非病的亚健康症状。如:
身体出现疲劳、虚弱、情绪改变等;
与年龄不相适应的组织结构或生理功能减退所致的各种虚弱表现;
微生态失衡状态;
某些疾病的病前生理病理学改变等,称之为亚健康主要特征和症状。
亚健康的临床表现多种多样,躯体方面可表现为疲乏无力、肌肉及关节酸痛、头昏头痛、心悸胸闷、睡眠紊乱、食欲不振、脘腹不适、便溏便秘、性功能减退、怕冷怕热、易于感冒、眼部干涩等;心理方面可表现有情绪低落、心烦意乱、焦躁不安、急躁易怒、恐惧胆怯、记忆力下降、注意力不能集中、精力不足、反应迟钝等;社会交往方面可表现有不能较好地承担相应的社会角色,工作、学习困难,不能正常地处理好人际关系、家庭关系,难以进行正常的社会交往等临床症状。
亚健康若不加以调节,就会导致疾病的发生,损害健康,如人体足部微生态失衡,引发脚气病(香港脚等)。
某些疾病的病前生理病理学改变,如血流不畅导致心悸胸闷、心烦意乱、焦躁不安、急躁易怒、睡眠紊乱或情绪改变等,极易引发高血压、心脏病等。
人体出现疲乏无力、肌肉及关节酸痛、食欲不振、脘腹不适等疲劳、虚弱现象,不加以调节会导致引发心、肺、胃肠等功能性疾病。
因而,人们十分渴求规避这些亚健康现象或症状在自身呈现。
但同时,人们又希望获得缓解或消除这些亚健康现象出现的症状是以不影响或占用工作、生活、学习为前提的。
发明内容
为实现上述目的,本发明提供一种中药与藏药结合的、具有养生保健功能的浴足液及其制备方法,具体地,本发明的浴足液的技术方案如下:
一种中藏药结合配方的精华养生浴足液,由以下(按照重量份计)的原料组成:藏菖蒲5-15、桉叶5-15、苦参5-15、红花5-15、鸡血藤3-9、川牛膝2-8、白术4-7、沙棘3.5-6.5、当归2.7-7.4、何首乌1.9-8.2、红景天0.5-1.5、雪莲花3-7、黄芪0.3-0.8、西洋参0.6-3、五味子0.7-2.5、熟地黄0.3-0.5、积雪草0.5-1和辣木籽0.4-1.2。
作为本发明的进一步方案,所述的一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲7-12、桉叶6-13、苦参8-12、红花9-11、鸡血藤4-8、川牛膝3-7、白术5-6、沙棘3.9-6.1、当归3.7-6.4、何首乌3.9-6.2、红景天0.6-1.3、雪莲花4-6、黄芪0.4-0.7、西洋参0.8-2、五味子0.9-2.1、熟地黄0.4-0.5、积雪草0.6-0.9和辣木籽0.5-1.1。
作为本发明的再进一步方案,所述的一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲10份、桉叶10份、苦参10份、红花10份、鸡血藤5份、川牛膝5份、白术5份、沙棘5份、当归5份、何首乌5份、红景天0.6-1.3、雪莲花5份、黄芪0.4-0.7、西洋参0.8-2、五味子0.9-2.1、熟地黄0.4-0.5、积雪草0.6-0.9和辣木籽0.5-1.1。
本发明的另一目的,是提供一种中藏药结合配方的精华养生浴足液的制备方法,由以下步骤组成:
1)将藏菖蒲、桉叶、红花、沙棘、当归、何首乌、西洋参、五味子按配方比例混合,得到组分A,使用饮用水淋洗后加入饮用水浸泡2-5小时;
2)浸泡组分A中通入蒸汽进行加热,保持提取罐内液体温度为85-90℃,常压下缓慢蒸馏;
3)收集组分A的馏出液,至没有液体流出为止,收集的馏出液即为组分A的处理液;
4)将苦参、鸡血藤、川牛膝、白术、红景天、雪莲花、黄芪、熟地黄、积雪草、辣木籽按配方比例混合,得到组分B,使用饮用水淋洗后,加饮用水煎煮2-4次,每次保持组分B微沸0.5-2小时,收集组分B煎煮液即为组分B的处理液;
5)合并组分A的处理液及组分B的处理液,真空浓缩,即得精华提取液,即,本发明的浴足液。
本发明的另一目的是提供所述浴足液类产品在保健养生领域纠正人体亚健康状态中的应用。
其中,本发明的产品为浴足液的精华液,在使用时或销售包装前可进行适当的或任意的稀释(如,1:10)。
为了解决背景技术所存在的问题,本发明提供了一种中藏药结合配方的精华养生浴足液,所述的药液涉及到的理论依据如下:
早在我国古代中医典籍《皇帝内经》素问·阴阳应象大论中记述:其有邪者,渍行以汗,渍是浸泡的意思,即把身体浸泡到热水或是稀释的外用药液中来达到出汗以驱邪气,这被认为最适用于表证,即疾病初起之时。
中医经络学认为:足部是足三阴经(足太阴脾经、足厥阴肝经、足少阴肾经)的起始点,又是足三阳经(足阳明胃经、足少阳胆经、足太阳膀胱经)的终止点,足部有六十多个穴位。
而刺激足部穴位,可增强气血运行,舒通经络,调理脏腑。
明代《琐碎录》记载:“足是人之底,一夜一次洗”,表明我国自古以来就有用足浴的方式来防病治病的传统。
现代医学的血液循环理论认为热水洗脚能使局部血管扩张,末稍神经兴奋,血液循环加快,增强新陈代谢,达到强身健体的目的。并认为足部在人体最底部,血液中的尿酸结晶等有害物质沉积在足部,可以通过足部按摩分解沉积在脚底的有害物质,使其通过汗液、尿液排出体外。
1975年,瑞士人玛鲁卡多提出了《足反射疗法》,经我国学者整理认为人的脏腑器官与足底穴位是一一对应的,足部按摩可以通过反射区促使大脑传导信号,改善人体内分泌和血液循环,调节人体生理环境。
这些学说从不同角度支持了传统中医的其有邪者,渍行以汗,也印证了我国民谚春天洗脚,开阳固脱;夏天洗脚,暑理可祛;秋天洗脚,肺润肠濡;冬天洗脚,丹田湿灼的科学性。
因而,中药浴足是中医治未病和内病外治的一种简单有效的方法。
本发明的中藏药配方制剂-精华浴足液是用传统热水足浴方法(洗脚)结合中医治未病和内病外治理论,在民间传统中医药验方基础上进行药物筛选的温经散寒、舒筋通络、祛风除湿、杀虫止痒的浴足配方。
人们可以用睡前一盆“精华浴足汤”达到缓解或消除部分人群因各种原因出现的疲乏无力、肌肉及关节酸痛、心烦意乱、焦躁不安、睡眠紊乱以及足部微生态失衡引起的肿痛瘙痒等亚健康症状。
作为本发明的关键核心,配方的组方成分筛选及组方内容,配方中各成分作用机理如下:
在民间传统足浴的不同验方基础上,如藏菖蒲煎汤洗澡,以避除秽恶之气的习俗(抑菌洁净皮肤)、桉叶、麻柳叶煎汤洗浴痱子,苦参药材煎汤洗浴皮肤瘙痒,红花药材煎汤足浴治“老茧”等,结合中医治未病和内病外治理论,用现代药用物质基础与药理学加以筛选。以藏、汉民间常外用于洗浴的藏菖蒲(抗致病菌(主要为真菌类)、促进伤口愈合与抗炎作用)、桉叶(抗致病菌(主要为细菌类)、抗痉挛、止痛、缓解肌肉酸痛及风湿痛等作用)、苦参(抗过敏、抗炎等作用)、红花(对足部胼胝有治疗作用,与鸡血藤配伍能缓解痛经和风湿疼痛),四味传统洗浴药物相互补充,互为加强构成配方的骨架,在此基础上进行与君药(主药)相关的其它药物的精细筛选,使不同的单一足浴验方经整理-组合为适应面宽广的经济实用的抗痉挛及风湿痛、缓解疲乏无力(温经散寒)、肌肉及关节酸痛(舒筋止痛)、痛经(祛风通络)、足部微生态失衡(除湿、杀虫止痒)引起的肿痛瘙痒、心烦意乱、焦躁不安、睡眠紊乱等亚健康症状的精华浴足配方。
配方中各味药材的药性及归经:
藏菖蒲:辛,温。归膀胱经。祛风,散寒,除湿,止痛。用于风寒感,巅顶疼痛,风湿痹痛。外用涂敷,有去湿疗疮、杀虫止痒之功。现代研究认为外用时具有很好的抗真菌作用和缓解疲乏无力、肌肉及关节酸痛。
桉叶:辛、苦,温,散寒解毒杀虫止痒。用于感冒,流感,痢疾,肠炎,关节痛,膀胱炎,烫伤,疥癣,丹毒,痈疮肿毒。外用能预防和缓解神经性皮炎,湿疹等,现代研究认为外用是最好的杀菌剂之一,同时有抗痉挛、止痛、缓解肌肉酸痛及风湿痛等作用。
苦参:苦,寒。归心、肝、胃、大肠、膀胱经。清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癖麻风;外治滴虫性阴道炎。
红花:性温,味辛。归心经、肝经。活血通经、散瘀止痛。外用对胼胝有治疗作用,与鸡血藤配伍能缓解痛经和风湿痛等。
鸡血藤:苦、甘,温。归肝、肾经。活血补血,调经止痛,舒筋活络。用于月经不调,痛经,经闭,风湿痹,麻木瘫痪,血虚萎黄。与红花配伍能缓解痛经和风湿痛等。
川牛膝:甘、微苦,平。归肝、肾经。用于经闭癥瘕,胞衣不下,跌扑损伤,风湿痹痛,足痿筋挛,尿血血淋。
白术:苦、甘,温。归脾、胃经。徤脾益气,燥湿利水,止汗,安胎。用于脾虛食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。
沙棘:酸、涩,温。归脾、胃、肺、心经。健脾消食,止咳祛痰,活血散瘀。用于脾虚食少,食积腹痛,咳嗽痰多,胸痹心痛,瘀血经闭,跌扑瘀肿。
当归:甘、辛,温。归肝、心、脾经。补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。
何首乌:苦、甘、涩,微温。归肝、心、肾经。解毒,消痈,截疟,润肠通便。用于疮痈,瘰疬,风疹瘙痒,久疟体虛,肠燥便秘。
红景天:甘、苦,平。归肺、心经。益气活血,通脉平喘。用于气虛血瘀,胸痹心痛,中风偏瘫,倦怠气喘。
雪莲花:微苦,温。入肾、脾、肺、肝经。用于风寒湿痹痛、类风湿性关节炎,小腹冷痛,月经不调。(藏、维医:补肾活血,强筋骨,营养神经,调节异常体液。用于风湿性关节炎,关节疼痛,肺寒咳嗽,肾与小腹冷痛,白带过多等)。
黄芪:甘,微温。归肺、脾经。补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
西洋参:根提取物甘、微苦,凉。归心、肺、肾经。补气养阴,清热生津。用于气虛阴亏,虛热烦倦,咳喘痰血,内热消渴,口燥咽干。
熟地黄:提取物甘,微温。归肝、肾经。补血滋明,益精填髓。用于血虚萎黄,心悸怔忡,月经不调,崩漏下血,肝肾阴虛,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,眩晕,耳鸣,须发早白。
积雪草:苦、辛,寒。归肝、脾、肾经。清热利湿,解毒消肿。用于湿热黄疸,中暑腹泻石淋血淋,痈肿疮毒,跌扑损伤。
五味子:酸、甘,温。归肺、心、肾经。收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗盗汗,津伤口渴,内热消渴,心悸失眠。
本发明使用传统中医药理论结合现代药用物质基础(化学成分)进行技术实现,本发明的精华浴足配方机理的优势在于:
1.配方的理论基础:(1)人体双足分布有60多个穴位与内外环境相通,经络循行线是由人体各部位的穴位点连接起来的,足三阴经、足三阳经以及足部丰富的穴位有着与人体五脏六腑密切相关的关系。精华浴足液中的有效药用组分(化学物质)具有刺激人体足部穴位和疏通人体经络的作用。
(2)通过人体足部足三阴经、足三阳经和60多个穴位与人体各脏腑器官相对应的反射区联系以及药液中的药用物质基础(化学成分)经足部皮肤的透皮吸收达到靶点部位。
(3)现代中药药理学认为:中药熏洗是经皮给药系统(TTS)方法的一种。许多辛香走窜的中药能“开腠理”,即开放皮肤的药物渗透通道,具有显著的透皮促渗作用。
2.配方组方的药用物质基础:
古代养生洗浴(尤其足浴)一般均就地取材,配方简单而应用面较窄,如我国民间在五月初五将菖蒲、艾叶、香薷等药材挂门上或菖蒲药材煎汤洗澡,以避除秽恶之气的习俗(主要为抑菌洁净空气或皮肤)。用桉叶、麻柳叶煎汤洗浴痱子(主要为抑菌和消除毛孔阻塞),苦参药材煎汤洗浴阴肿阴痒、皮肤瘙痒(主要为抑菌与抗炎),红花药材煎汤足浴治“老茧”(主要为抑制足肿胀)等。
而本发明的精华浴足液在以上传统足浴配方的基础上,结合现代药用物质基础与现代药理研究成果进行整理筛选,确定以藏菖蒲、桉叶、苦参、红花为主要药物组成具有散寒止痛、祛风通络、杀虫止痒功效的足浴配方。依据如下:
(1)菖蒲:药用分为藏菖蒲(Acorus calamus)和石菖蒲(Acorus tatarinowii)两种。根据四川各地五月初五市售菖蒲和西藏各地洗浴用菖蒲的考证与实物鉴定确定为藏菖蒲(Acorus calamus)更适于作为本发明的原料,藏菖蒲的主要洗浴用化学物质基础为挥发油类物质(β-细辛醚83.2%)与皂苷类物质。现代药理实验结果表明β-细辛醚对红色毛癣菌等多种真菌的抑制作用较强,藏菖蒲乙酸乙酯提取物对黄曲霉菌、犬小抱子菌、黑曲霉、隐球菌、大肠杆菌和白色念珠菌具有显著的抑菌活性,该提取物还有降血糖作用;藏菖蒲乙醇提取物具有促进伤口愈合的作用与抗炎作用。精华浴足液选用藏菖蒲提取挥发油类物质(上述方法工艺使β-细辛醚的提取达到70%)。
(2)桉叶:主要的洗浴用化学物质基础为挥发油类物质(1,8-桉叶素80.0%),1,8-桉叶素有抗痉挛、止痛、缓解肌肉酸痛及风湿痛等作用,桉叶提取物(桉精油)具有消除毛孔阻塞、消除粉刺、促进血液循环、帮助细胞组织再生(澳洲土著将捣碎的桉叶敷于伤口上,伤口愈合情形出乎意料地好)的作用,目前全世界将桉精油作为最好的杀菌剂之一进行生产。而桉精油均可从桉叶、月桂叶、香樟中提取得到。经考证与市场调研,蓝桉叶(Eucalyptusglobulus)在我国南方栽培量大,四川广泛栽种,其叶价廉物美,又符合传统用药要求,故在精华浴足液中作为君药收入。精华浴足液选用蓝桉叶提取挥发油类物质(工艺使1,8-桉叶素70-80.0%)。
(3)苦参:主要的洗浴用化学物质基础为生物碱类物质(以苦参碱、氧化苦参碱含量最高),苦参碱能对HBV有强有力的抗病毒活性和抑灭淋球菌,白念珠球菌等致病微生物的作用,氧化苦参碱能调节免疫和升高白细胞而具有抗过敏、抗炎作用。水煎剂在体外对常见的皮肤真菌有不同程度的抑制作用。故在精华浴足液中作为君药收入。精华浴足液选用苦参药材水提取物(或苦参全株水提取物)。
(4)红花:药用分为红花(Carthamus tinctorius)和藏红花(Crocus sativus),藏红花与红花都有活血化瘀通经的作用。藏红花为进口药物,降格昂贵,红花在我国四川、云南、新疆大量栽培。尤以川红花为道地药材,藏红花价格为红花的200-300倍。经考证与筛选确定在精华浴足液中红花作为君药收入。红花的主要洗浴用化学物质基础为皂苷类(红花苷,前红花苷、红花黄色素A及B等)与酚类(绿原酸、儿茶酚等)物质。红花水提取物、红花黄色素均有增加冠脉血流量及心肌营养性血流量的作用以及外用对甲醛性足肿胀有明显抑制作用。精华浴足液选用红花药材水提取物(红花与市售标有藏红花的浴足液比较价格低上百倍,其能消除足部老茧更利于红花黄色素的透皮吸收)。
以上洗浴药物中,藏菖蒲、桉叶、红花,辛,温,按现代药理定义均能“开腠理”。藏菖蒲侧重足部皮肤致病微生物真菌类的抑制,桉叶侧重足部皮肤致病微生物细菌类的抑制,在药用物质基础上(β-细辛醚、1,8-桉叶素)相互补充,互为加强而具有广泛的足部抗致病微生物(即药材杀虫止痒功效)和消除毛孔阻塞、促进血液循环(药材祛风通络、散寒止痛功效)作用。红花侧重促进血液循环,增加冠脉血流量及心肌营养性血流量(药材活血通经、散瘀止痛功效)和消除甲醛性足肿胀(足底老茧)。苦参苦,寒,可调节菖蒲、桉叶、红花的辛,温,不致药性太偏和太过。其主要药用物质在抗足部皮肤致病微生物(药材杀虫止痒功效)的基础上调节免疫和升高白细胞而达到抗过敏、抗炎(药材清热燥湿功效)的作用。
四味君药(主药)相互补充,互为加强构成温经散寒、舒筋通络、祛风除湿、杀虫止痒的精华浴足配方的骨架。
臣药:红景天中的红景天苷有明显的镇静催眠作用,鸡血藤能增强红花缓解痛经和风湿疼痛作用,川牛膝用于风湿痹痛,足痿筋挛作用明显可以加强红花的舒筋通络(活血)作用;沙棘、当归的活血补血、调经止痛的功效,可以从另一方面(补血)缓解脚膝肿痛、四肢拘挛、脚气浮肿、关节曲伸不利等症状,精华浴足配方中的臣药弥补了君药(主药)对足部微生态失衡、痛经和风湿疼痛引起的肿痛瘙痒、心烦意乱、焦躁不安、睡眠紊乱的不足。
佐、使药物:雪莲花(次生代谢物主要成分为黄酮类化合物与萜类及其衍生物,具有消炎镇痛作用)、白术、何首乌、蒙古黄芪、西洋参等药性味苦、甘,可平衡君药的辛味,其补气益肾、利湿消肿功效可以弥补臣药的补气不足,使达到补血补气以缓解心烦意乱、焦躁不安、睡眠紊乱、食欲不振、脘腹不适等症状。使其能够适宜人体气血不足而又有足部微生态失衡、痛经和风湿疼痛的亚健康人群。
配方中君、臣、佐、使各司其职,苦寒药物与温补药物或润或调,统一指挥,协调作战,经过人体穴位与经络传导以及部分有效药物组分的透皮吸收而具有抗痉挛及风湿痛、缓解疲乏无力(温经散寒)、肌肉及关节酸痛(舒筋止痛)、痛经(祛风通络)、足部微生态失衡(除湿、杀虫止痒)引起的肿痛瘙痒、心烦意乱、焦躁不安、睡眠紊乱等亚健康症状。有目的的调理人体各脏腑气血功能,即可修复和强化人体各系统的自主功能,抑制衰退,抗菌抑菌,从而达到缓解或消除部分人群因各种原因出现的微生态失衡或身体出现疲劳、虚弱、情绪改变引起的亚健康症状。
同时,根据本发明不同原料的性质,本发明提供的制备方法对其进行分类提取处理,分别进行煎煮或蒸馏。分门别类,操作简便且提取比例高。与本领域传统操作相比(例如,CN106389583A,需要对中药材进行九蒸九晒的前处理),大大缩减了操作工序,并且与单一的传统提取操作相比(例如,CN105148111A,其使用了16味中药的水萃取的方法,由于其药材相互配伍的机理不明确,无药材间的相互协同作用,同时采用直接用水煎煮的提取方式,使得药材的有效成分流失严重),分类提取、真空浓缩的工艺,也最大限度的保留原料中的有效成分。
具体实施方式
为方便本领域人员更好地理解本发明,现在给出本发明的具体实施方式;本发明中所描述的实施方式仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域类的技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲10份、桉叶10份、苦参10份、红花10份、鸡血藤5份、川牛膝5份、白术5份、沙棘5份、当归5份、何首乌5份、红景天1份、雪莲花5份、黄芪0.5份、西洋参1份、五味子1份、熟地黄0.5份、积雪草0.8份、辣木籽1份。
将藏菖蒲、桉叶、红花、沙棘、当归、何首乌、西洋参、五味子按配方比例混合,得到组分A,使用3倍重量饮用水淋洗后加入2倍重量饮用水浸泡2小时。浸泡组分A中通入蒸汽进行加热,保持提取罐内液体温度为88℃,常压下缓慢蒸馏。收集组分A的馏出液,至没有液体流出为止,即得组分A的处理液。将苦参、鸡血藤、川牛膝、白术、红景天、雪莲花、黄芪、熟地黄、积雪草、辣木籽按配方比例混合,得到组分B,使用3倍重量饮用水淋洗后,加饮用水煎煮2次,每次保持组分B微沸1小时,收集组分B的煎煮液(过滤后)即为组分B的处理液。合并组分A的处理液及组分B的处理液,真空浓缩,即得精华提取液。使用精华提取液按照工艺比例加入煮沸后的去离子水,苯甲酸钠即得精华浴足液。
实施例2
本发明实施例中,一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲5份、桉叶5份、苦参5份、红花5份、鸡血藤3份、川牛膝2份、白术4份、沙棘3.5份、当归2.7份、何首乌1.9份、红景天0.5份、雪莲花3份、黄芪0.3份、西洋参0.6份、五味子0.7份、熟地黄0.3份、积雪草0.5份、辣木籽0.4份。
将藏菖蒲、桉叶、红花、沙棘、当归、何首乌、西洋参、五味子按配方比例混合,得到组分A,使用2倍重量饮用水淋洗后加入3倍重量饮用水浸泡5小时。浸泡组分A中通入蒸汽进行加热,保持提取罐内液体温度为87℃,常压下缓慢蒸馏。收集组分A的馏出液,至没有液体流出为止,即得组分A的处理液。将苦参、鸡血藤、川牛膝、白术、红景天、雪莲花、黄芪、熟地黄、积雪草、辣木籽按配方比例混合,得到组分B,使用2倍重量饮用水淋洗后,加饮用水煎煮3次,每次保持组分B微沸0.5小时,收集组分B煎煮液即为组分B的处理液。合并组分A的处理液及组分B的处理液,真空浓缩,即得精华提取液。使用精华提取液按照工艺比例加入煮沸后的去离子水,苯甲酸钠即得精华浴足液。
实施例3
本发明实施例中,一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲15份、桉叶15份、苦参15份、红花15份、鸡血藤9份、川牛膝8份、白术7份、沙棘6.5份、当归7.4份、何首乌8.2份、红景天1.5份、雪莲花7份、黄芪0.8份、西洋参3份、五味子2.5份、熟地黄0.5份、积雪草1份、辣木籽1.2份。
将藏菖蒲、桉叶、红花、沙棘、当归、何首乌、西洋参、五味子按配方比例混合,得到组分A,使用2.5倍重量饮用水淋洗后加入2.5倍重量饮用水浸泡2小时。浸泡组分A中通入蒸汽进行加热,保持提取罐内液体温度为86℃,常压下缓慢蒸馏。收集组分A的馏出液,至没有液体流出为止,即得组分A的处理液。将苦参、鸡血藤、川牛膝、白术、红景天、雪莲花、黄芪、熟地黄、积雪草、辣木籽按配方比例混合,得到组分B,使用2.5倍重量饮用水淋洗后,加饮用水煎煮3次,每次保持组分B微沸2小时,收集组分B煎煮液即为组分B的处理液。合并组分A的处理液及组分B的处理液,真空浓缩,即得精华提取液。使用精华提取液按照工艺比例加入煮沸后的去离子水,苯甲酸钠即得精华浴足液。
实施例4
一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲10份、桉叶10份、苦参10份、红花10份、鸡血藤5份、川牛膝5份、白术5份、沙棘5份、当归5份、何首乌5份、红景天0.6份、雪莲花5份、黄芪0.7份、西洋参2份、五味子1份、熟地黄0.5份、积雪草0.6份、辣木籽1份。制备方法同实施例1。
实施例5
一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲7份、桉叶13份、苦参8份、红花11份、鸡血藤5份、川牛膝3份、白术5份、沙棘6份、当归4份、何首乌4份、红景天0.6份、雪莲花6份、黄芪0.7份、西洋参1份、五味子0.9份、熟地黄0.4份、积雪草0.7份、辣木籽0.5份。制备方法同实施例1。
实施例6
一种中藏药结合配方的精华养生浴足液,由以下按照重量份的原料组成:藏菖蒲10份、桉叶6份、苦参11份、红花9份、鸡血藤4份、川牛膝7份、白术5.8份、沙棘6份、当归6.4份、何首乌6份、红景天1.2份、雪莲花5份、黄芪0.7份、西洋参1.2份、五味子2份、熟地黄0.4份、积雪草0.9份、辣木籽1.1份。制备方法同实施例1。
实验例
下面就100例亚健康症状人群应用该养生浴足液后的效果报告如下:
1.患者资料:100例亚健康人群,男性39例,女性61例,最大年龄75岁,最小年龄15岁。
2.患者采用双盲试验法随机分为空白组50人(热水浴足),配方应用组50人(精华浴足液浴足)。
3.将制备好的10倍稀释的本发明的浴足液400ml(采用实施例1),放入有恒温装置的足浴盆中,再加入适量温水(根据足浴盆的大小,可适当增减水量,以水浸到足内外踝为宜),加热到40℃,将双脚放入浴足液中浸泡30分钟,每天下午或睡前泡脚一次,20天为一个疗程,症状严重者每天泡脚2次。
4.疗效评价:
无效-症状无改善。
有效-症状有所缓解。
显效-症状显著改善或部分消除。
5.结果:
患者亚健康评价指标按,照睡眠紊乱,肌肉及关节酸痛,疲乏无力头昏,脚气、瘙痒,脚膝肿痛关节曲伸不利五个评价指标综合测评。
50例亚健康空白组(热水浴足),亚健康改善状况,无效49例,有效1例,显效0例;50例配方应用组(精华浴足液浴足),显效47例,有效50例,无效0例,整体有效率100%。
具体地,按照上述的较为普遍的各评价指标,双盲实验后,使用本发明的浴足液产品的50名患者的具体见效结果如下表1中所示。
表1.使用实施例1的产品的50名患者的具体指标改善情况
从上表可以看出,本发明的产品对于睡眠质量提升、肌肉关节症状缓解、精神状态改善、以及脚部真菌类疾病问题等亚健康典型症状均具有非常明显的改善作用,一般在5天作用大部分患者的身体状况和精神状态即可得到明显改善。并且,经过两个疗程的患者的半年回访改善作用保持率为96%。
6.典型病例:
病例一:张某某,女,18岁,学生。症状:心慌气短,胸闷憋气,心烦意乱,惶惶无措,周期性头痛。经医院确诊为:因心理压力引起的神经性头痛。通过外用本发明浴足液,一个疗程(一疗程二十天),头痛症状明显好转,继续使用本发明的浴足液一个疗程,主诉症状全部消失,经检查已恢复正常。
病例二:陈某某,男,27岁,互联网公司项目主管。症状:由于长期加班导致失眠,间歇性眩晕,心烦易怒,记忆力减退。经医院确诊为:焦虑性失眠。通过外用本发明浴足液,一个疗程(一疗程二十天),失眠症状消失,继续使用本发明的浴足液一个疗程,主诉症状全部消失。经随访半年无复发。
病例三:王某某,女,44岁,上市公司高管。症状:突发性地恶心、呕吐、焦躁、神经衰弱、精神疲惫。经医院确诊为:慢性焦虑症。通过外用本发明浴足液,一个疗程(一疗程二十天),焦虑症状消失,继续使用本发明的浴足液二个疗程,主诉症状全部消失。经随访一年无复发。
此外,应当理解,虽然本说明书按照实施方式进行了详细描述,但并非每个实施方式仅包含一个独立的技术方案,说明书所采用的这种叙述妨碍仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可进行适当组合,形成本领域技术人员可以理解的其它实施方式。
Claims (2)
1.一种中藏药结合的浴足液在制备改善亚健康状况的产品中的应用,所述亚健康状况是睡眠紊乱,肌肉及关节酸痛,疲乏无力头昏,脚气、瘙痒和脚膝肿痛关节曲伸不利;其特征在于,所述浴足液是以重量份计由按以下比例的原料组成:
藏菖蒲7-12、桉叶6-13、苦参8-12、红花9-11、鸡血藤4-8、川牛膝3-7、白术5-6、沙棘3.9-6.1、当归3.7-6.4、何首乌3.9-6.2、红景天0.6-1.3、雪莲花4-6、黄芪0.4-0.7、西洋参0.8-2、五味子0.9-2.1、熟地黄0.4-0.5、积雪草0.6-0.9和辣木籽0.5-1.1;
其中,所述浴足液的制备方法为:
1)将藏菖蒲、桉叶、红花、沙棘、当归、何首乌、西洋参、五味子按比例混合,得到组分A,用水淋洗后加水浸泡2-5小时;
2)向浸泡的组分A中通入蒸汽进行加热,保持提取罐内液体温度为85-90℃,以在常压下进行缓慢蒸馏;
3)收集组分A的馏出液,至没有液体流出为止,收集的馏出液即为组分A的处理液;
4)将苦参、鸡血藤、川牛膝、白术、红景天、雪莲花、黄芪、熟地黄、积雪草、辣木籽按比例混合,得到组分B,用水淋洗后,加水煎煮2-4次,每次保持组分B的混合物微沸0.5-2小时,收集组分B的过滤的煎煮液即为组分B的处理液;
5)合并组分A的处理液及组分B的处理液,真空浓缩,即得所述浴足液。
2.根据权利要求1中所述的应用,其特征在于,所述浴足液是按重量份计由以下按比例的原料组成:
藏菖蒲10份、桉叶10份、苦参10份、红花10份、鸡血藤5份、川牛膝5份、白术5份、沙棘5份、当归5份、何首乌5份、红景天0.6-1.3、雪莲花5份、黄芪0.4-0.7、西洋参0.8-2、五味子0.9-2.1、熟地黄0.4-0.5、积雪草0.6-0.9和辣木籽0.5-1.1。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711166127.0A CN107951966B (zh) | 2017-11-21 | 2017-11-21 | 一种中藏药结合的浴足液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711166127.0A CN107951966B (zh) | 2017-11-21 | 2017-11-21 | 一种中藏药结合的浴足液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107951966A CN107951966A (zh) | 2018-04-24 |
CN107951966B true CN107951966B (zh) | 2023-01-06 |
Family
ID=61965126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711166127.0A Active CN107951966B (zh) | 2017-11-21 | 2017-11-21 | 一种中藏药结合的浴足液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107951966B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108813610B (zh) * | 2018-05-30 | 2022-03-04 | 南京中生生物科技有限公司 | 一种用于提高免疫力的雪莲组合物及其应用 |
KR102554647B1 (ko) * | 2018-10-18 | 2023-07-12 | 상하이 주쿠 코스메틱 씨오., 엘티디 | 족욕 제제 및 그의 제조 방법 |
CN113101315A (zh) * | 2021-04-30 | 2021-07-13 | 张馨予 | 一种中医药足浴包 |
EP4351724A1 (en) * | 2021-06-11 | 2024-04-17 | CompleMedic Z ApS | Composition comprising centella extract and hippophae extract |
CN116059154A (zh) * | 2021-10-29 | 2023-05-05 | 李宏亮 | 一种藏药八味泷沐组合物 |
CN115715786A (zh) * | 2022-11-24 | 2023-02-28 | 成都天泉源药业有限公司 | 一种用于治疗皮肤病或减轻症状的中药组合物及洗剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2208947Y (zh) * | 1994-12-02 | 1995-10-04 | 吴成荣 | 足心药疗保健袋 |
CN1239668A (zh) * | 1998-06-19 | 1999-12-29 | 谢天方 | 心脑通脉口服液及其制备方法 |
CN1426799A (zh) * | 2001-12-18 | 2003-07-02 | 张英林 | 按摩液 |
CN102366472A (zh) * | 2011-10-20 | 2012-03-07 | 邓华伦 | 治疗失血过多,阴云气弱的中草药 |
CN104056096A (zh) * | 2014-06-18 | 2014-09-24 | 合肥瑾翔医药科技有限公司 | 一种补气养血的中药组合物 |
CN104605357B (zh) * | 2015-02-12 | 2016-05-18 | 董广鹏 | 一种调理亚健康的功能性保健品 |
CN105832947A (zh) * | 2016-05-09 | 2016-08-10 | 张金贵 | 一种养生保健的泡脚中草药粉 |
CN105963450A (zh) * | 2016-07-08 | 2016-09-28 | 孟广千 | 治疗眩晕昏厥的中药组合物 |
CN106728955A (zh) * | 2016-12-06 | 2017-05-31 | 李胜利 | 一种治疗肢体疼痛、麻木的热敷药 |
-
2017
- 2017-11-21 CN CN201711166127.0A patent/CN107951966B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107951966A (zh) | 2018-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107951966B (zh) | 一种中藏药结合的浴足液 | |
CN103251867B (zh) | 一种治疗糖尿病的中药复方药物及其制备方法 | |
CN102119989B (zh) | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 | |
CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN103055066A (zh) | 改善睡眠的中药及其制备方法 | |
CN105641668A (zh) | 浴足洗浴中药组合物 | |
CN104547598A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN103977164A (zh) | 一种治疗心绞痛的中药制剂及制备方法 | |
CN104740042A (zh) | 一种治疗慢性咽炎的中药组合物 | |
CN106924503A (zh) | 一种治疗肝癌的中药组合物及其制备方法 | |
CN111973667A (zh) | 一种降低甲胎蛋白的药茶配方 | |
CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
CN104435592A (zh) | 一种治疗突发性耳聋耳鸣的中药及制法 | |
CN104815045A (zh) | 一种用于中医针灸的中药方剂及制备方法 | |
CN109276687A (zh) | 一种补气活血药酒及其制备方法 | |
CN104666799A (zh) | 软组织损伤活血化瘀药酒及制备方法 | |
CN104013950A (zh) | 一种治疗蕴毒腐溃型褥疮的中药组合物及其制备方法 | |
CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
CN107412679A (zh) | 排毒保健品及其制备方法和应用 | |
CN105944036A (zh) | 一种用于辅助治疗抑郁症的中药组合物 | |
CN106106919A (zh) | 一种含有黄皮叶的保健茶饮料及其制备方法 | |
CN105998592A (zh) | 一种用于治疗颈椎病的中药 | |
CN114146129A (zh) | 用于改善睡眠的中药组合物、包含其的足浴包及应用 | |
CN104587297A (zh) | 一种治疗硬皮症的中药胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |